FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049254927> ?p ?o ?g. }

• W3049254927 abstract "Abstract Background Reliable quantification of dopamine transporter (DAT), a biomarker for Parkinson’s disease (PD), is essential for diagnostic purposes as well as for evaluation of potential disease-modifying treatment. Due to degeneration of dopaminergic neurons and thus lower expected radioligand binding to DAT, higher measurement variability in PD patients might be expected than earlier reproducibility results in healthy controls. Therefore, we aimed to examine the test-retest properties of [ 18 F]FE-PE2I-PET in PD patients. Methods Nine patients with PD (Hoehn and Yahr stage < 3) were included (men/women 6/3; mean age 65.2 ± 6.8 years). Each patient underwent two [ 18 F]FE-PE2I-PET measurements within 7–28 days. The outcome measure was non-displaceable binding potential generated using wavelet-aided parametric imaging with cerebellum as reference region. We assessed test-retest performance using estimates of reliability and repeatability. Regions for primary analysis were caudate, putamen, ventral striatum, and substantia nigra. Exploratory analysis was performed for functional subdivisions of the striatum. We also compared the more vs. less affected side. Results [ 18 F]FE-PE2I showed absolute variability estimates of 5.3–7.6% in striatal regions and 11% in substantia nigra and ICCs of 0.74–0.97 (median 0.91). The absolute variability for functional striatal subdivisions was 6.0–9.6% and ICCs of 0.76–0.91 (median 0.91). The less affected substantia nigra exhibited greater consistency than the more affected side. According to power calculations based on the current sample size, DAT changes of 5–11% in the striatum and 28% in the substantia nigra can be detected with a power of 0.8 ( p < 0.0125). Conclusion DAT-PET measurements with [ 18 F]FE-PE2I in PD patients showed good repeatability and reliability. The slightly lower reliability in the substantia nigra in patients may be explained by lower DAT density and smaller anatomical size. Power calculations suggest that [ 18 F]FE-PE2I PET is a suitable marker for longitudinal DAT decline in PD. Trial registration EudraCT 2017-003327-29" @default.
• W3049254927 created "2020-08-21" @default.
• W3049254927 creator A5002443674 @default.
• W3049254927 creator A5008812904 @default.
• W3049254927 creator A5015456048 @default.
• W3049254927 creator A5019976313 @default.
• W3049254927 creator A5026942684 @default.
• W3049254927 creator A5036364090 @default.
• W3049254927 creator A5049341241 @default.
• W3049254927 creator A5071263952 @default.
• W3049254927 creator A5081327813 @default.
• W3049254927 date "2020-08-14" @default.
• W3049254927 modified "2023-10-16" @default.
• W3049254927 title "Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease" @default.
• W3049254927 cites W1899551010 @default.
• W3049254927 cites W1939719114 @default.
• W3049254927 cites W1943795612 @default.
• W3049254927 cites W1961156775 @default.
• W3049254927 cites W1978793506 @default.
• W3049254927 cites W1980721081 @default.
• W3049254927 cites W1981781645 @default.
• W3049254927 cites W1988296887 @default.
• W3049254927 cites W1991394330 @default.
• W3049254927 cites W1993576606 @default.
• W3049254927 cites W2032654155 @default.
• W3049254927 cites W2033756513 @default.
• W3049254927 cites W2041457250 @default.
• W3049254927 cites W2052631606 @default.
• W3049254927 cites W2074076764 @default.
• W3049254927 cites W2086080603 @default.
• W3049254927 cites W2090295694 @default.
• W3049254927 cites W2095358363 @default.
• W3049254927 cites W2098290220 @default.
• W3049254927 cites W2105153214 @default.
• W3049254927 cites W2118231277 @default.
• W3049254927 cites W2124767905 @default.
• W3049254927 cites W2136152004 @default.
• W3049254927 cites W2155408421 @default.
• W3049254927 cites W2171800484 @default.
• W3049254927 cites W2405891631 @default.
• W3049254927 cites W2508329305 @default.
• W3049254927 cites W2604395256 @default.
• W3049254927 cites W2629203717 @default.
• W3049254927 cites W2783013682 @default.
• W3049254927 cites W2792171782 @default.
• W3049254927 cites W2795120583 @default.
• W3049254927 cites W2901905026 @default.
• W3049254927 cites W2921107593 @default.
• W3049254927 cites W2950800651 @default.
• W3049254927 doi "https://doi.org/10.1186/s13550-020-00676-4" @default.
• W3049254927 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7427674" @default.
• W3049254927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32797307" @default.
• W3049254927 hasPublicationYear "2020" @default.
• W3049254927 type Work @default.
• W3049254927 sameAs 3049254927 @default.
• W3049254927 citedByCount "13" @default.
• W3049254927 countsByYear W30492549272021 @default.
• W3049254927 countsByYear W30492549272022 @default.
• W3049254927 countsByYear W30492549272023 @default.
• W3049254927 crossrefType "journal-article" @default.
• W3049254927 hasAuthorship W3049254927A5002443674 @default.
• W3049254927 hasAuthorship W3049254927A5008812904 @default.
• W3049254927 hasAuthorship W3049254927A5015456048 @default.
• W3049254927 hasAuthorship W3049254927A5019976313 @default.
• W3049254927 hasAuthorship W3049254927A5026942684 @default.
• W3049254927 hasAuthorship W3049254927A5036364090 @default.
• W3049254927 hasAuthorship W3049254927A5049341241 @default.
• W3049254927 hasAuthorship W3049254927A5071263952 @default.
• W3049254927 hasAuthorship W3049254927A5081327813 @default.
• W3049254927 hasBestOaLocation W30492549271 @default.
• W3049254927 hasConcept C126322002 @default.
• W3049254927 hasConcept C134018914 @default.
• W3049254927 hasConcept C137183658 @default.
• W3049254927 hasConcept C2776755682 @default.
• W3049254927 hasConcept C2779134260 @default.
• W3049254927 hasConcept C2779714222 @default.
• W3049254927 hasConcept C2779734285 @default.
• W3049254927 hasConcept C2780062018 @default.
• W3049254927 hasConcept C2780938664 @default.
• W3049254927 hasConcept C2989005 @default.
• W3049254927 hasConcept C513476851 @default.
• W3049254927 hasConcept C71924100 @default.
• W3049254927 hasConceptScore W3049254927C126322002 @default.
• W3049254927 hasConceptScore W3049254927C134018914 @default.
• W3049254927 hasConceptScore W3049254927C137183658 @default.
• W3049254927 hasConceptScore W3049254927C2776755682 @default.
• W3049254927 hasConceptScore W3049254927C2779134260 @default.
• W3049254927 hasConceptScore W3049254927C2779714222 @default.
• W3049254927 hasConceptScore W3049254927C2779734285 @default.
• W3049254927 hasConceptScore W3049254927C2780062018 @default.
• W3049254927 hasConceptScore W3049254927C2780938664 @default.
• W3049254927 hasConceptScore W3049254927C2989005 @default.
• W3049254927 hasConceptScore W3049254927C513476851 @default.
• W3049254927 hasConceptScore W3049254927C71924100 @default.
• W3049254927 hasFunder F4320322315 @default.
• W3049254927 hasFunder F4320322581 @default.
• W3049254927 hasFunder F4320323375 @default.
• W3049254927 hasFunder F4320327918 @default.
• W3049254927 hasIssue "1" @default.
• W3049254927 hasLocation W30492549271 @default.

• next